$100 would be nice for us small ihub options holders! I'll take $35, though. :)
Does it seem unusual that the FDA had a press release on the approval, but HGSI/GSK haven't? I thought the FDA held off for a few days on press releases? Or is that just on CRLs?
So far, limitations on sales don't seem too severe, although HGSI/GSK will have to run a trial in African Americans.
GSK is up $1.42 in after-hours. I briefly forgot that I typed in GSK for a quote, saw the $40 SP, and nearly dropped my keyboard...until I remembered it was GSK I was looking at. Rats!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.